# An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

> **NCT01078675** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 315 (actual)

## Conditions studied

- Familial Hypercholesterolaemia

## Interventions

- **DRUG:** rosuvastatin calcium
- **DRUG:** rosuvastatin calcium
- **DRUG:** rosuvastatin calcium

## Key facts

- **NCT ID:** NCT01078675
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2015-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078675, "An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01078675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*